Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder: A preliminary analysis

G. R. Fries, J. Quevedo, C. P. Zeni, I. F. Kazimi, G. Zunta-Soares, D. E. Spiker, C. L. Bowden, C. Walss-Bass, J. C. Soares

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

First-degree relatives of patients with bipolar disorder (BD), particularly their offspring, have a higher risk of developing BD and other mental illnesses than the general population. However, the biological mechanisms underlying this increased risk are still unknown, particularly because most of the studies so far have been conducted in chronically ill adults and not in unaffected youth at high risk. In this preliminary study we analyzed genome-wide expression and methylation levels in peripheral blood mononuclear cells from children and adolescents from three matched groups: BD patients, unaffected offspring of bipolar parents (high risk) and controls (low risk). By integrating gene expression and DNA methylation and comparing the lists of differentially expressed genes and differentially methylated probes between groups, we were able to identify 43 risk genes that discriminate patients and high-risk youth from controls. Pathway analysis showed an enrichment of the glucocorticoid receptor (GR) pathway with the genes MED1, HSPA1L, GTF2A1 and TAF15, which might underlie the previously reported role of stress response in the risk for BD in vulnerable populations. Cell-based assays indicate a GR hyporesponsiveness in cells from adult BD patients compared to controls and suggest that these GR-related genes can be modulated by DNA methylation, which poses the theoretical possibility of manipulating their expression as a means to counteract the familial risk presented by those subjects. Although preliminary, our results suggest the utility of peripheral measures in the identification of biomarkers of risk in high-risk populations and further emphasize the potential role of stress and DNA methylation in the risk for BD in youth.

Original languageEnglish (US)
Article numbere1059
JournalTranslational Psychiatry
Volume7
Issue number3
DOIs
StatePublished - Jan 1 2017

Fingerprint

Gene Expression Profiling
Bipolar Disorder
Glucocorticoid Receptors
DNA Methylation
Genes
Vulnerable Populations
Methylation
Population
Blood Cells
Chronic Disease
Research Design
Biomarkers
Parents
Genome
Gene Expression

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience
  • Biological Psychiatry

Cite this

Fries, G. R., Quevedo, J., Zeni, C. P., Kazimi, I. F., Zunta-Soares, G., Spiker, D. E., ... Soares, J. C. (2017). Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder: A preliminary analysis. Translational Psychiatry, 7(3), [e1059]. https://doi.org/10.1038/tp.2017.32

Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder : A preliminary analysis. / Fries, G. R.; Quevedo, J.; Zeni, C. P.; Kazimi, I. F.; Zunta-Soares, G.; Spiker, D. E.; Bowden, C. L.; Walss-Bass, C.; Soares, J. C.

In: Translational Psychiatry, Vol. 7, No. 3, e1059, 01.01.2017.

Research output: Contribution to journalArticle

Fries, GR, Quevedo, J, Zeni, CP, Kazimi, IF, Zunta-Soares, G, Spiker, DE, Bowden, CL, Walss-Bass, C & Soares, JC 2017, 'Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder: A preliminary analysis', Translational Psychiatry, vol. 7, no. 3, e1059. https://doi.org/10.1038/tp.2017.32
Fries, G. R. ; Quevedo, J. ; Zeni, C. P. ; Kazimi, I. F. ; Zunta-Soares, G. ; Spiker, D. E. ; Bowden, C. L. ; Walss-Bass, C. ; Soares, J. C. / Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder : A preliminary analysis. In: Translational Psychiatry. 2017 ; Vol. 7, No. 3.
@article{e46f7db6c30f4497abab3cbbddde4002,
title = "Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder: A preliminary analysis",
abstract = "First-degree relatives of patients with bipolar disorder (BD), particularly their offspring, have a higher risk of developing BD and other mental illnesses than the general population. However, the biological mechanisms underlying this increased risk are still unknown, particularly because most of the studies so far have been conducted in chronically ill adults and not in unaffected youth at high risk. In this preliminary study we analyzed genome-wide expression and methylation levels in peripheral blood mononuclear cells from children and adolescents from three matched groups: BD patients, unaffected offspring of bipolar parents (high risk) and controls (low risk). By integrating gene expression and DNA methylation and comparing the lists of differentially expressed genes and differentially methylated probes between groups, we were able to identify 43 risk genes that discriminate patients and high-risk youth from controls. Pathway analysis showed an enrichment of the glucocorticoid receptor (GR) pathway with the genes MED1, HSPA1L, GTF2A1 and TAF15, which might underlie the previously reported role of stress response in the risk for BD in vulnerable populations. Cell-based assays indicate a GR hyporesponsiveness in cells from adult BD patients compared to controls and suggest that these GR-related genes can be modulated by DNA methylation, which poses the theoretical possibility of manipulating their expression as a means to counteract the familial risk presented by those subjects. Although preliminary, our results suggest the utility of peripheral measures in the identification of biomarkers of risk in high-risk populations and further emphasize the potential role of stress and DNA methylation in the risk for BD in youth.",
author = "Fries, {G. R.} and J. Quevedo and Zeni, {C. P.} and Kazimi, {I. F.} and G. Zunta-Soares and Spiker, {D. E.} and Bowden, {C. L.} and C. Walss-Bass and Soares, {J. C.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1038/tp.2017.32",
language = "English (US)",
volume = "7",
journal = "Translational Psychiatry",
issn = "2158-3188",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Integrated transcriptome and methylome analysis in youth at high risk for bipolar disorder

T2 - A preliminary analysis

AU - Fries, G. R.

AU - Quevedo, J.

AU - Zeni, C. P.

AU - Kazimi, I. F.

AU - Zunta-Soares, G.

AU - Spiker, D. E.

AU - Bowden, C. L.

AU - Walss-Bass, C.

AU - Soares, J. C.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - First-degree relatives of patients with bipolar disorder (BD), particularly their offspring, have a higher risk of developing BD and other mental illnesses than the general population. However, the biological mechanisms underlying this increased risk are still unknown, particularly because most of the studies so far have been conducted in chronically ill adults and not in unaffected youth at high risk. In this preliminary study we analyzed genome-wide expression and methylation levels in peripheral blood mononuclear cells from children and adolescents from three matched groups: BD patients, unaffected offspring of bipolar parents (high risk) and controls (low risk). By integrating gene expression and DNA methylation and comparing the lists of differentially expressed genes and differentially methylated probes between groups, we were able to identify 43 risk genes that discriminate patients and high-risk youth from controls. Pathway analysis showed an enrichment of the glucocorticoid receptor (GR) pathway with the genes MED1, HSPA1L, GTF2A1 and TAF15, which might underlie the previously reported role of stress response in the risk for BD in vulnerable populations. Cell-based assays indicate a GR hyporesponsiveness in cells from adult BD patients compared to controls and suggest that these GR-related genes can be modulated by DNA methylation, which poses the theoretical possibility of manipulating their expression as a means to counteract the familial risk presented by those subjects. Although preliminary, our results suggest the utility of peripheral measures in the identification of biomarkers of risk in high-risk populations and further emphasize the potential role of stress and DNA methylation in the risk for BD in youth.

AB - First-degree relatives of patients with bipolar disorder (BD), particularly their offspring, have a higher risk of developing BD and other mental illnesses than the general population. However, the biological mechanisms underlying this increased risk are still unknown, particularly because most of the studies so far have been conducted in chronically ill adults and not in unaffected youth at high risk. In this preliminary study we analyzed genome-wide expression and methylation levels in peripheral blood mononuclear cells from children and adolescents from three matched groups: BD patients, unaffected offspring of bipolar parents (high risk) and controls (low risk). By integrating gene expression and DNA methylation and comparing the lists of differentially expressed genes and differentially methylated probes between groups, we were able to identify 43 risk genes that discriminate patients and high-risk youth from controls. Pathway analysis showed an enrichment of the glucocorticoid receptor (GR) pathway with the genes MED1, HSPA1L, GTF2A1 and TAF15, which might underlie the previously reported role of stress response in the risk for BD in vulnerable populations. Cell-based assays indicate a GR hyporesponsiveness in cells from adult BD patients compared to controls and suggest that these GR-related genes can be modulated by DNA methylation, which poses the theoretical possibility of manipulating their expression as a means to counteract the familial risk presented by those subjects. Although preliminary, our results suggest the utility of peripheral measures in the identification of biomarkers of risk in high-risk populations and further emphasize the potential role of stress and DNA methylation in the risk for BD in youth.

UR - http://www.scopus.com/inward/record.url?scp=85037588602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037588602&partnerID=8YFLogxK

U2 - 10.1038/tp.2017.32

DO - 10.1038/tp.2017.32

M3 - Article

C2 - 28291257

AN - SCOPUS:85037588602

VL - 7

JO - Translational Psychiatry

JF - Translational Psychiatry

SN - 2158-3188

IS - 3

M1 - e1059

ER -